Sort   by:  
 Page size 
UnknownIntravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
Not available
S-EPMC5648171 | biostudies-literature
UnknownHematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies.
Not available
S-EPMC4549230 | biostudies-literature
UnknownCyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.
Not available
S-EPMC2849314 | biostudies-literature
UnknownStructure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.
Not available
S-EPMC4547362 | biostudies-literature
UnknownMITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer.
Not available
S-EPMC2628456 | biostudies-literature
UnknownPARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancer.
Not available
S-EPMC12936415 | biostudies-literature
UnknownIntravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Not available
S-EPMC7988888 | biostudies-literature
UnknownImplementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
Not available
S-EPMC7430215 | biostudies-literature
Sort   by:  
 Page size